Capricor Therapeutics Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CAPR Nasdaq 2836 https://capricor.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Capricor Therapeutics Inc

When Will Capricor Therapeutics, Inc. (NASDAQ:CAPR) Become Profitable? - Mar 20th, 2023 3:27 pm
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2022 Earnings Call Transcript - Mar 18th, 2023 7:12 am
Capricor Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update - Mar 15th, 2023 8:01 pm
Capricor Therapeutics to Present Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Update on March 15 - Mar 8th, 2023 2:00 pm
Capricor Therapeutics Receives Clinical Research Forum’s 2023 Top Ten Clinical Research Achievement Award - Mar 2nd, 2023 2:15 pm
Capricor Therapeutics and Nippon Shinyaku Enter Partnership for Exclusive Commercialization and Distribution of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy in Japan - Feb 16th, 2023 2:25 pm
Capricor Therapeutics Announces Positive 18-Month Results from Ongoing HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy Patients - Jan 25th, 2023 1:00 pm
Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar to Provide Recent Updates on CAP-1002 Program - Jan 19th, 2023 9:05 pm
Capricor Highlights Preclinical Data From Its Closed COVID-19 Vaccine Study - Jan 12th, 2023 5:55 pm
Capricor Announces Publication Highlighting New Advances for its Engineered Exosome Platform - Jan 12th, 2023 2:26 pm
Capricor (CAPR) Upgraded to Buy: What Does It Mean for the Stock? - Jan 11th, 2023 5:00 pm
Despite shrinking by US$18m in the past week, Capricor Therapeutics (NASDAQ:CAPR) shareholders are still up 194% over 3 years - Dec 10th, 2022 12:46 pm
2 “Strong Buy” Penny Stocks That Could Rally All the Way to $15 - Nov 30th, 2022 3:35 pm
Capricor Therapeutics Third Quarter 2022 Earnings: Beats Expectations - Nov 13th, 2022 12:18 pm
Capricor Therapeutics (CAPR) Reports Q3 Loss, Tops Revenue Estimates - Nov 10th, 2022 10:15 pm
Edited Transcript of CAPR.OQ earnings conference call or presentation 10-Nov-22 9:30pm GMT - Nov 10th, 2022 9:30 pm
Capricor Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update - Nov 10th, 2022 9:01 pm
Capricor Therapeutics to Present Third Quarter 2022 Financial Results and Recent Corporate Update on November 10 - Nov 3rd, 2022 8:01 pm
Capricor Therapeutics to Present One-Year Results from HOPE-2 Open Label Extension Study at World Muscle Society 2022 - Oct 6th, 2022 1:00 pm
Capricor Therapeutics to Present at Upcoming Investor Conferences - Sep 7th, 2022 12:00 pm